Rates of diagnosed ADHD in England remain significantly lower than the academic consensus on the condition’s actual prevalence, according to a population-based study published in The Lancet Regional Health Europe on June 15, 2026. The findings indicate a substantial gap in diagnosis, particularly among older adults and individuals assigned female at birth, challenging public perceptions that rising diagnosis rates are driven by the medicalization of everyday life.
Why is there a gap between ADHD prevalence and diagnosis?
The discrepancy between recorded ADHD cases and actual prevalence stems from limitations in diagnostic tools and societal barriers. Dr. Rachel Moseley, a Principal Academic in Psychology at Bournemouth University, notes that diagnostic sensitivity often varies across demographics. Many established measures for identifying neurodivergence remain less effective for girls and women, leading to systemic under-diagnosis. While some media reports characterize recent increases in ADHD diagnoses as “spurious” or financially motivated, the study suggests these figures likely reflect a long-standing backlog of individuals who have struggled without professional support or adequate accommodations.
Research indicates that “milder” cases of ADHD—where symptoms are less extreme or immediately visible—are frequently missed by clinical systems, leading to long-term negative outcomes for patients.
What are the long-term costs of undiagnosed ADHD?
Failing to identify ADHD in both children and adults carries significant individual and societal consequences. According to evidence cited by Dr. Moseley, including work from the UK’s Independent ADHD Taskforce, undiagnosed individuals often experience higher rates of mental health conditions, substance use issues, and disengagement from education or employment. The failure to provide timely interventions creates an “exorbitant” cost for society, whereas formal diagnosis is increasingly recognized as a life-saving tool that allows for necessary, life-altering accommodations.
How do diagnosis trends compare to public perception?
There is a distinct contrast between the narrative of “over-diagnosis” and the data presented by researchers. While the UK’s March 2026 Independent Review into Mental Health Conditions, Autism and ADHD raised concerns regarding the rising incidence of diagnoses, the study by Amber John et al. corroborates a body of work suggesting the actual problem is a lack of identification. Previous research by McKechnie et al. (2023) and Cortese et al. (2026) aligns with the new findings, suggesting that the current surge in individuals seeking help is not an artificial trend, but a necessary correction for a previously underserved population.
Pro Tip: Accessing Support
If you suspect you or a family member may have undiagnosed ADHD, focus on documenting how symptoms impact daily functioning rather than comparing your experience to stereotypes. Clinical assessments are designed to identify functional impairment, not just behavioral “extremes.”
Frequently Asked Questions
- Is ADHD being over-diagnosed?
- Current population-based data suggests the opposite. Research indicates that diagnosed rates are actually lower than expected, particularly in women and older adults.
- Why is it harder to get an ADHD diagnosis as an adult?
- Diagnostic tools have historically been calibrated for children, often failing to account for how ADHD symptoms manifest or are masked in adult life.
- What is the primary risk of remaining undiagnosed?
- Beyond individual health struggles, undiagnosed ADHD is linked to increased risks of mental health crises, addiction, and long-term unemployment.
Have you or a loved one navigated the diagnosis process? Join the conversation in the comments below or subscribe to our newsletter for the latest updates on neurodiversity research and policy.
